Advertisement

Topics

Yoshitomi Pharmaceutical Industries Limited Company Profile

07:16 EDT 24th June 2018 | BioPortfolio

Anti-Bacterial

Location

6-7Yushima 1-chome Bunkyo-ku
Tokyo
Tokyo
113
Japan

Contact

Phone: 81 3 5802 0600
Fax: 81 3 5802 0609


News Articles [1037 Associated News Articles listed on BioPortfolio]

Comparing Teva Pharmaceutical Industries

Amgen and Teva Pharmaceutical Industries are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional owne...

Weekly Analysts' Ratings Changes for Teva Pharmaceutical Industries

A number of firms have modified their ratings and price targets on shares of Teva Pharmaceutical Industries recently: 1/22/2018 - Teva Pharmaceutical Industries was given a new $20.00 price target on ...

Teva Pharmaceutical Industries (TEVA) Set to Announce Earnings on Thursday

Teva Pharmaceutical Industries will be posting its quarterly earnings results before the market opens on Thursday, February 8th. Analysts expect Teva Pharmaceutical Industries to post earnings of $0.7...

Kal Sundaram appointed as chairman of Taro Pharmaceutical

Taro Pharmaceutical Industries Ltd. (Taro) announced that Dilip Shanghvi has resigned, effective April 18, as chairman and a member of Taro's board of directors in order to focus on other growth prior...

TEVA Pharmaceutical Industries: Die Käufer kämpfen sich zurück!

Am 2. November erreichte die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries bei 10,85 US-Dollar ein Tief, von dem aus der Kurs bis zum 12. Januar wieder kontinuierlich anstieg. Das b...

TEVA Pharmaceutical Industries: Wie geht es nun weiter?

Liebe Leser, am 2. November erreichte die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries bei 10,85 US-Dollar ein Tief, von dem aus der Kurs bis zum 12. Januar wieder kontinuierlich a...

TEVA Pharmaceutical Industries: Die 50-Tagelinie gilt es zu überwinden!

Am 2. November erreichte die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries bei 10,85 US-Dollar ein Tief, von dem aus der Kurs bis zum 12. Januar wieder kontinuierlich anstieg. Das b...

TEVA Pharmaceutical Industries: Der Verkaufsdruck lässt nach!

Liebe Leser, am 2. November erreichte die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries bei 10,85 US-Dollar ein Tief, von dem aus der Kurs bis zum 12. Januar wieder kontinuierlich a...

PubMed Articles [592 Associated PubMed Articles listed on BioPortfolio]

Prioritizing Type of Industry through Health Risk Assessment of Occupational Exposure to Dimethylformamide in the Workplace.

The purpose of this study was to classify hazards at an industrial level and evaluate the exposure risks of workers exposed to dimethylformamide (DMF) used as a solvent in the workplace and to determi...

A network analysis of indirect carbon emission flows among different industries in China.

Indirect carbon emissions account for a large ratio of the total carbon emissions in processes to make the final products, and this implies indirect carbon emission flow across industries. Understandi...

Dynamic Flux Balance Analysis Using DFBAlab.

Bioprocesses are of critical importance in several industries such as the food and pharmaceutical industries. Despite their importance and widespread application, bioprocess models remain rather simpl...

Production of ophthalmic acid using engineered Escherichia coli.

Ophthalmic acid (l-γ-glutamyl-l-2-aminobutyryl-glycine, OA) is an analog of glutathione (l-γ-glutamyl-l-cysteinyl-glycine, GSH) in which the cysteine moiety is replaced by l-2-aminobutyrate. OA is a...

Orphan drugs: trends and issues in drug development.

Research in rare diseases has contributed substantially toward the current understanding in the pathophysiology of the common diseases. However, medical needs of patients with rare diseases have alway...

Clinical Trials [319 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Rivaroxaban from Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Indust...

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

The objective of this study is to evaluate the comparative bioavailability between tamsulosin hydrochloride 0.4 mg capsules (Manufactured by Teva Pharmaceutical Industries Ltd.; distribute...

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

Lansoprazole 30 mg DR Capsule Fasting Study

The object of this study is to compare the relative bioavailability of lansoprazole 30 mg delayed-release capsules (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by ...

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions

The study will compare the relative bioavailability (rate and extent of absorption) of 200 mg/5 mL Azithromycin oral suspension manufactured by TEVA Pharmaceutical Industries Ltd.; distrib...

Companies [2267 Associated Companies listed on BioPortfolio]

Yoshitomi Pharmaceutical Industries Limited

Anti-Bacterial

AARTI INDUSTRIES LIMITED

The first unit of AARTI group, ALCHEMIE LABORATORIES, commenced commercial production of DIMETHYL SULPHATE (DMS) in the year 1975. Today, AARTI has acquired world-class expertise in the development an...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

BARAKAT Pharmaceutical Industries

BARAKAT Pharmaceutical Industries is one of the leading-well established and most inveterate Syrian private companies specializing in the production of human medicines. The Company was founded in 1972...

EFPIA (The European Federation of Pharmaceutical Industries and Associations)

EFPIA (The European Federation of Pharmaceutical Industries and Associations) represents the research-based pharmaceutical industry operating in Europe.Through its direct membership of 28 national pha...

More Information about "Yoshitomi Pharmaceutical Industries Limited" on BioPortfolio

We have published hundreds of Yoshitomi Pharmaceutical Industries Limited news stories on BioPortfolio along with dozens of Yoshitomi Pharmaceutical Industries Limited Clinical Trials and PubMed Articles about Yoshitomi Pharmaceutical Industries Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Yoshitomi Pharmaceutical Industries Limited Companies in our database. You can also find out about relevant Yoshitomi Pharmaceutical Industries Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record